Perfil
William H.
Collier currently works at Genevant Sciences Corp., as Director.
Mr. Collier also formerly worked at Arbutus Biopharma Corp., as President, Chief Executive Officer & Director from 2019 to 2023, Arbutus Biopharma, Inc., as President & Chief Executive Officer, International Partnership for Microbicides, as Director from 2018 to 2021, Glaxowellcom, as Area Director, Aids United, as Director from 2011 to 2018, and ViiV Healthcare Ltd., as President & GM-North America Region.
Mr. Collier received his undergraduate degree from the University of Manchester Institute of Science & Technology.
Cargos activos de William Collier
| Empresas | Cargo | Inicio |
|---|---|---|
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de William Collier.
| Empresas | Cargo | Fin |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director Ejecutivo | 31/12/2023 |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Director Ejecutivo | 31/12/2023 |
International Partnership for Microbicides
International Partnership for Microbicides BiotechnologyHealth Technology Develop human immunodeficiency virus prevention products | Director/Miembro de la Junta | 01/01/2021 |
Aids United
Aids United Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for HIV epidemics | Director/Miembro de la Junta | 01/01/2018 |
Glaxowellcom | Corporate Officer/Principal | - |
Formación de William Collier.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
International Partnership for Microbicides
International Partnership for Microbicides BiotechnologyHealth Technology Develop human immunodeficiency virus prevention products | Health Technology |
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Health Technology |
University of Manchester Institute of Science & Technology
University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glaxowellcom | |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Aids United
Aids United Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for HIV epidemics | Commercial Services |
- Bolsa de valores
- Insiders
- William Collier
















